Literature DB >> 20719586

Clinical inertia in management of T2DM.

Azhar Zafar1, M Davies, A Azhar, Kamlesh Khunti.   

Abstract

Diabetes is highly prevalent and serious chronic debilitating disease and reported to be the fourth main cause of death in Europe. Despite extensive evidence of benefits of tight glycemic control, large proportions of people with diabetes do not achieve target glycemic control. One major reason for this is clinical inertia which is "recognising the problem but failure to act" by health care professionals in primary care. The key issues in the management of people with T2DM include early detection of problems, realistic goal setting, improved patient adherence, better knowledge and understanding of pharmacotherapeutic treatment options and prompt intervention. Health care professionals must need to overcome clinical inertia and need to intensify therapy in an appropriate and timely manner.
Copyright © 2010 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20719586     DOI: 10.1016/j.pcd.2010.07.003

Source DB:  PubMed          Journal:  Prim Care Diabetes        ISSN: 1878-0210            Impact factor:   2.459


  30 in total

1.  Pharmaceutical care program for type 2 diabetes patients in Brazil: a randomised controlled trial.

Authors:  Aline Oliveira Magalhães Mourão; Wandiclécia Rodrigues Ferreira; Maria Auxiliadora Parreiras Martins; Adriano Max Moreira Reis; Maria Ruth Gaede Carrillo; Andrea Grabe Guimarães; Lisiane Silveira Ev
Journal:  Int J Clin Pharm       Date:  2012-11-18

2.  Therapeutic Inertia: Still a Long Way to Go That Cannot Be Postponed.

Authors:  Manel Mata-Cases; Josep Franch-Nadal; Mònica Gratacòs; Dídac Mauricio
Journal:  Diabetes Spectr       Date:  2020-02

3.  The effect of chromium on inflammatory markers, 1st and 2nd phase insulin secretion in type 2 diabetes.

Authors:  Yen-Lin Chen; Jiunn-Diann Lin; Te-Lin Hsia; Frank Chiahung Mao; Chun-Hsien Hsu; Dee Pei
Journal:  Eur J Nutr       Date:  2013-03-14       Impact factor: 5.614

4.  Therapeutic Inertia in People With Type 2 Diabetes in Primary Care: A Challenge That Just Won't Go Away.

Authors:  Nemin Adam Zhu; Stewart B Harris
Journal:  Diabetes Spectr       Date:  2020-02

5.  A longitudinal study examining adherence to guidelines in diabetes care according to different definitions of adequacy and timeliness.

Authors:  Grigory Sidorenkov; Flora M Haaijer-Ruskamp; Dick de Zeeuw; Petra Denig
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

6.  Chronic non-communicable diseases in Cameroon - burden, determinants and current policies.

Authors:  Justin B Echouffo-Tcheugui; Andre P Kengne
Journal:  Global Health       Date:  2011-11-23       Impact factor: 4.185

7.  The impact of treatment noncompliance on mortality in people with type 2 diabetes.

Authors:  Craig J Currie; Mark Peyrot; Christopher Ll Morgan; Chris D Poole; Sara Jenkins-Jones; Richard R Rubin; Christopher M Burton; Marc Evans
Journal:  Diabetes Care       Date:  2012-04-17       Impact factor: 19.112

8.  Is therapeutic inertia present in hyperglycaemia, hypertension and hypercholesterolaemia management among adults with type 2 diabetes in three health clinics in Malaysia? a retrospective cohort study.

Authors:  Boon-How Chew; Husni Hussain; Ziti Akthar Supian
Journal:  BMC Fam Pract       Date:  2021-06-11       Impact factor: 2.497

9.  Physician perceptions and practices in management of diabetes in India: Results from the IMPROVE Control program.

Authors:  A G Unnikrishnan; S K Wangnoo; S R Joshi; S Banerjee; A Kumar; S Kalra; R Channabasavaiah; R Shetty
Journal:  Indian J Endocrinol Metab       Date:  2012-12

10.  Baseline results indicate poor glycemic control and delay in initiation and optimization of insulin therapy: results from the improving management practices and clinical outcomes in type 2 diabetes study.

Authors:  C R Anand Moses; V Seshiah; B K Sahay; A Kumar; A J Asirvatham; V Balaji; S Kalra; S Akhtar; R Shetty; A K Das
Journal:  Indian J Endocrinol Metab       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.